Earnings calls / AXISCADES · August 13, 2026

AXISCADES Technologies Ltd Q1 FY27 Earnings Call Summary

Q1 FY27 consolidated revenue hit a record ₹346 cr, up 42% YoY, but reported PAT was a ₹14.8 cr loss due to ₹21.81 cr divestment costs and ₹13.1 cr provisions; normalized continuing EBITDA was ₹41 cr (11.8%) on defense revenue of ₹125 cr (up 112% YoY) and ZEDA at ~30% margin. The real driver is the shift from services to manufacturing, with aerospace manufacturing revenue of only ₹6.1 cr against ₹19.3 cr costs and ADR Solutions losing ₹4.8 cr EBITDA. Management reaffirmed FY27 guidance of ₹1,377 cr revenue, ₹270 cr EBITDA, ~₹135 cr PAT, backed by two acquisitions closing this quarter and ₹1,255 cr extraordinary gain from the US$237 mn divestment. Main risk: acquisition or divestment slippage, which would delay ₹715 cr cash inflows and Power 930's ₹960 cr FY30 PAT target.

Revenue
Margin
Demand
Guidance
Tone

AXISCADES Technologies Ltd - Q1 FY27 Earnings Call Summary Thursday, August 13, 2026 5:30 PM IST

Event Participants

Executives

4
D Murali Krishnan, KP Mohanakrishnan, Mukund Santhanam, Shankhini Saha

Analysts

8
Balasubramanian, Deepak Poddar, Jatin Jadhav, Koushik Mohan, Mahek Talati, Mayur Parkeria, Piyush Sarawagi, Praful Rai

Financials & KPIs

Metric Reported Commentary
Consolidated Revenue ₹346 crores Up 42% YoY, 27% QoQ; highest on record; split ₹163 cr discontinued + ₹183 cr continuing
Continuing Operations Revenue ₹183 crores Up 94% YoY from ₹94 crores; defense + ZEDA + aerospace manufacturing
Aerospace Manufacturing Revenue ₹6.1 crores Negative EBITDA; ₹12.9 cr operating cost + ₹6.4 cr finance cost (72% of retained finance cost)
Defense Revenue ₹125 crores Up 112% YoY; underlying EBITDA ₹13 cr (up 15% YoY); reported EBITDA ₹2.6 cr after ₹9.6 cr one-time costs
ZEDA (eSI) Revenue ₹49.5 crores Up 63% YoY; EBITDA ₹14.7 cr at ~30% margin; business transfer contributed 46% EBITDA margin
Reported EBITDA (Combined) ₹27.9 crores Includes ₹13.1 cr one-off provisions (₹9.62 cr defense receivable + ₹3.5 cr hedge unwind)
Normalized EBITDA (Continuing) ₹41 crores (11.8% margin) Up from ₹20.5 crores YoY; excludes ₹13.1 cr provisions and ₹21.81 cr transaction cost
Reported PAT -₹14.8 crores vs ₹20.9 crores PAT in Q1 FY26; driven by divestment-related one-offs
Normalized PAT ₹20.2 crores Normalized PBT ₹23.1 crores; reflects the business actually operated
Cash ₹81 crores Up 78%; ahead of first tranche of divestment proceeds
Assured Forecast Visibility ₹4,557 crores To be executed by FY30; ₹332 cr added in Q1 via design/order wins
Deferred Revenue Recovery ~₹60 crores of ₹142 crores ~40% converted in Q1; balance planned across Q2/Q3
Employee Cost 44% of revenue Down from 53% YoY despite hiring for manufacturing pivot
PPE +₹40 crores QoQ Capacity build for Power 930 ramp-up

Geographic & Segment Commentary

  • Defense: Record revenue of ₹125 crores in Q1 FY27, up 112% YoY, representing over two-thirds of continuing revenue. Underlying EBITDA of ₹13 crores (up 15% YoY) was dragged down by ₹9.6 crores of one-time receivable provisioning costs (reported EBITDA ₹2.6 crores at 9.7% underlying margin). Order wins include 30kW laser directed energy weapon ToT, BrahMos onboard electronics production orders, helicopter ERP, and Uttam radar antenna beam control systems; forecast visibility now at ₹4,557 crores, with a total pipeline exceeding ₹24,000 crores across unmanned systems, missiles, and radar/EW.

  • ZEDA (formerly eSI, now US-headquartered): Revenue of ₹49.5 crores, up 63% YoY, with EBITDA of ₹14.7 crores at ~30% margin. Added two marquee global technology customers — a semiconductor equipment manufacturer and the world's largest AI/hyperscale tech company — via a business transfer that contributed a 46% EBITDA margin. Management expects >100% YoY growth in FY27 on the back of organic growth, acquisitions, and the US-domiciled platform's customer proximity.

  • Aerospace Manufacturing: Revenue of ₹6.1 crores with negative EBITDA, reflecting front-loaded investment ahead of revenue with a 30-member leadership team in place. Operating cost of ₹12.9 crores and ₹6.4 crores finance cost (72% of retained finance cost) sit against minimal revenue as the manufacturing ramp begins. A non-binding offer for an AS9100-certified precision manufacturing company is in advanced due diligence (expected close Q2 FY27), with annualized FY27 revenue of ₹180 crores and EBITDA of ₹39 crores at 22% margin targeted.

  • ADR Solutions (Europe, non-core): Recorded ₹4.8 crores EBITDA loss and ₹6.7 crores PAT loss, constituting most of the continuing business loss of ₹7.04 crores for the quarter. Loss-making and non-core; exit action plan underway with closure targeted by Q4 FY27.

Company-Specific & Strategic Commentary

  • Divestment & Proceeds Deployment: Accordis transaction valued at US$237 million (₹2,256 crores), shareholder-approved July 27, closing in two phases — Phase 1 by August 31 (₹190 crores post-tax cash) and Phase 2 by November 30 (₹525 crores). Extraordinary gain of ~₹1,255 crores to be recorded on completion (₹200+ crores recognized in Q2). Proceeds fund Power 930 and acquisitions with no equity dilution.

  • Manufacturing Infrastructure Build: DAC (Devanahalli Aeronautics Complex) fully commissioned with supply chain/logistics, testing labs, and SMT lines operational. Construction underway at the Missile Complex in Hyderabad (groundbreaking July 2026), and the CAM (Center for Advanced Manufacturing, 240,000 sq ft on 20 acres at Devanahalli) is positioned as a quad-use facility for aerospace, defense, space, and electronics. CapEx is timed to divestment inflows, with a bridge facility of ₹100–250 crores drawdown available.

  • Power 930 Execution: Company is executing on its stated transition from services to manufacturing/product; engineering services divested May 2026 and aerospace services June 2026. Employee cost fell from 53% to 44% of revenue while hiring for the manufacturing pivot. FY27 revenue guidance of ₹1,377 crores on continuing operations (annualized pro forma) and EBITDA of ₹270 crores reaffirmed; FY30 PAT target of ₹960 crores (FY24 revenue base) maintained.

Guidance & Outlook

Metric Guidance / Outlook Commentary
FY27 Revenue (continuing ops, annualized pro forma) ₹1,377 crores Reaffirmed; organic growth in defense/ZEDA plus inorganic acquisitions replacing divested revenue
FY27 EBITDA ₹270 crores Divested EBITDA to be replaced at a fraction of the sale price via aerospace and ZEDA acquisitions plus organic growth
FY27 PAT ~₹135 crores ~50% of EBITDA; could be higher as divestment proceeds pay down debt and reduce interest costs
Defense Growth >75% YoY over next several years Backed by ₹4,557 crores assured visibility to be executed by FY30
ZEDA Growth >100% in FY27 Organic growth plus acquisitions and business partnerships
Deferred Revenue Recovery ~₹82 crores in Q2/Q3 FY27 ~₹60 crores recovered in Q1 out of ₹142 crores deferral
Aerospace Manufacturing Run Rate ₹375 crores revenue, ₹84 crores EBITDA by Q4 FY27 AS9100 acquisition + second transaction under evaluation + organic growth; replaces divested EBITDA
ADR Solutions Exit Q4 FY27 Non-core; action plan underway
Divestment Closings Engineering Services Phase 1 by Aug 31, Phase 2 by Nov 30 ~₹190 crores then ~₹525 crores post-tax cash; extraordinary gain of ~₹1,255 crores recorded on closing
Space Partnerships Announcements at Bangalore Space Expo and World Space Business Week (Paris), Q2 FY27 Strategic global partnerships for technology, orders, and market entry

Risks & Constraints

Risk Context
Acquisition Slippage Aerospace and ZEDA acquisitions are at advanced stages (NBO issued, DD near close) but completions are binary; management maintains pipeline depth with third and fourth acquisitions in due diligence; Power 930 targets are contingent on successful closes
Divestment Closing Delays Phase 1 (Aug 31) and Phase 2 (Nov 30) timelines are committed; slippage would delay ₹715 crores of cash inflows and impact CapEx timing; bridge facility of ₹100–250 crores drawdown available as mitigation
Defense Receivable Recovery ₹9.62 crores aged Ministry of Defence receivable provisioned conservatively (±₹6.5 cr on MoD order + ₹3.14 cr on defense PSU); recovery continues to be pursued with the Ministry
ADR Solutions Continuing Losses ₹4.8 crores EBITDA loss and ₹6.7 crores PAT loss in Q1 constitute most of the continuing business loss; remains a drag until exit targeted Q4 FY27
Manufacturing Pivot Cost Overlap Aerospace manufacturing carries ₹12.9 crores operating cost and ₹6.4 crores finance cost against only ₹6.1 crores revenue; front-loaded costs before the acquisition and ramp-up close
Execution Risk on Power 930 Targets require all divestments, acquisitions, and organic growth to close on schedule; management remains confident, noting each deliverable is on track with committed timelines

Q&A Highlights

Aerospace Services Divestment Rationale

  • Question: Why divest aerospace services given its ~₹70–80 crores annual EBITDA? Could services and manufacturing coexist? (Deepak Poddar)
  • Answer: Services OEMs are consolidating; selling to a global leader at a strong price and redeploying proceeds into Power 930 enabled funding without equity dilution. Manufacturing is a stickier, more predictable business leveraging defense, space, and electronics capabilities for end-to-end solutions. (Mukund Santhanam, KP Mohanakrishnan)

Provision Accounting Treatment

  • Question: Where are the ₹22 crores of provisions (₹9.62 cr receivables, ₹3.5 cr hedge, ₹21.81 cr deal cost) accounted? (Deepak Poddar)
  • Answer: The ₹21.81 crores transaction cost sits in discontinued operations as an exceptional item (notes to accounts). The ₹6.5 crores MoD order provision, ₹3.14 crores defense PSU provision, and ₹3.5 crores hedge unwind provision are in continuing operations' other expenses. (Shankhini Saha)

FY27 PAT Guidance & Ramp

  • Question: What is the expected PAT level, given EBITDA is normalized? Can Q2–Q4 ramp to deliver? (Koushik Mohan)
  • Answer: EBITDA guided at ₹270 crores; PAT expected at broadly 50% of that (~₹135 crores), potentially higher with debt paydown from divestment proceeds. Acquisitions will contribute to top and bottom line from Q2–Q4. (Mukund Santhanam)

Acquisition Pipeline & Timing

  • Question: What is the status of acquisitions? (Koushik Mohan)
  • Answer: Aerospace acquisition (NBO issued, advanced DD) closing by Q2; second aerospace transaction under evaluation for Q4. ZEDA business transfer closing this quarter. Additional acquisitions in non-binding stage — one expected in Q3, one in Q4; announcements will follow binding agreements. (KP Mohanakrishnan, Mukund Santhanam)

Defense Order Execution & Pipeline

  • Question: What is the execution timeline for the ₹4,500+ crores visibility, and what is the target order intake? (Praful Rai)
  • Answer: Visibility spans ~3 years (by FY30), with defense revenue guided to grow >75% YoY in FY27. Pipeline exceeds ₹24,000 crores across unmanned systems, missiles, and radar/EW. (D Murali Krishnan, Mukund Santhanam)

Power 930 Reaffirmation

  • Question: Are Power 930 targets still valid after the restructuring? (Praful Rai)
  • Answer: All components remain firm — sector focus, services-to-manufacturing transition, and targets. The FY24 revenue of ₹960 crores is the FY30 PAT target; divestment proceeds, acquisitions, and organic growth support achievement. (Mukund Santhanam)

Project Kusha, LUH Maritime & MBDA

  • Question: What is the update on Project Kusha qualification, LUH Maritime delivery, and MBDA expansion? (Mahek Talati, Piyush Sarawagi)
  • Answer: Deeper on 4 Kusha modules (mobile mast, electronics, digital beamforming unit); competition landscape not disclosed. LUH Maritime has ₹150–170 crores of confirmed orders, well on track. MBDA: ~5 test benches per year for next 3 years, expanding from Mica/Meteor to CAM/Aster platforms; pursuing Make-in-India on Rafale (local missile assembly, large electronics production) with announcements expected. (D Murali Krishnan)

BrahMos Seeker Development

  • Question: What is the update on BrahMos seekers? (Piyush Sarawagi)
  • Answer: Advanced prototype stage with customer endorsement. Developing two seekers — one with current AESA spec technology and one with proprietary direct RF technology — plus a seeker for a second missile. Revenue visibility from next financial year. (D Murali Krishnan)

Divestment Timelines, CapEx & Extraordinary Gain

  • Question: What are the year-wise CapEx plans and timing of the ₹1,255 crores extraordinary gain? (Balasubramanian)
  • Answer: ~₹200+ crores of extraordinary gain recognized in Q2 on Phase 1 closing; remainder by early Q3. CapEx timed to inflows (Q2/Q3 FY27, FY28, FY29), with bridge facility drawdown capped at ₹100–250 crores. No annual CapEx breakdown due to acquisitions' binary timing and partner-specific build requirements. (Shankhini Saha, Mukund Santhanam)

Subsidiary-Level Strategic Partnerships

  • Question: Are strategic JV partnerships with OEMs still on the cards given the strong cash position post-divestment? (Mayur Parkeria)
  • Answer: Conversations ongoing with existing and new OEM clients. Partnerships are about more than capital — commitment on dedicated facilities, IP, and access. Relationship progression: customer → partner → JV. No public timeline yet. (Mukund Santhanam)

Key Takeaway

AXISCADES Technologies delivered record consolidated revenue of ₹346 crores (up 42% YoY, 27% QoQ) in Q1 FY27 but reported a ₹14.8 crores PAT loss, driven by ₹21.81 crores divestment transaction costs, ₹13.1 crores provisions (defense receivable and hedge unwind), and transition cost overlap from the Accelus divestment (US$237 million). Continuing operations grew 94% YoY to ₹183 crores, with defense posting record ₹125 crores (up 112%) and ZEDA delivering ₹49.5 crores at ~30% EBITDA margin; normalized EBITDA was ₹41 crores (11.8% margin) and normalized PAT ₹20.2 crores. Management reaffirmed FY27 guidance of ₹1,377 crores revenue, ₹270 crores EBITDA, and ~₹135 crores PAT on an annualized pro forma basis, with two acquisitions closing this quarter, deferred revenue recovery completing by Q3, and ~₹1,255 crores extraordinary gain to be recorded on divestment completion. The strategy remains anchored on the Power 930 roadmap to ₹960 crores PAT by FY30, with ₹4,557 crores assured defense visibility and aerospace manufacturing targeting a ₹375 crores revenue/₹84 crores EBITDA run rate by Q4 FY27. Key watch points include acquisition closing execution, ADR Solutions exit (targeted Q4 FY27), and the successful ramp of manufacturing capacity funded by divestment proceeds.

What you get with InvestorStack

Institutional-grade research, built for individual investors.

  • Research Reports for every listed Indian company
  • Detailed valuation models
  • Growth triggers, Risks, KPIs, Read between the lines
  • Scans, One pagers, Industry research reports
Try for free